COMMUNIQUÉS West-GlobeNewswire

Best Cutting Steroids - Cycles & Top Weight Loss Steroids to Get Ripped & Shredded By Crazybulk

20/04/2025 - 12:51

Albany, New York, April 20, 2025 (GLOBE NEWSWIRE) -- Bodybuilders and athletes running a cutting cycle are endlessly searching for the best options to accelerate the fat-burning rate while retaining muscle. This article [...]

Riyadh Ignites Global Healthcare Innovation at MESH Core 2025

20/04/2025 - 12:53

Mass General Brigham and Saudi healthcare leaders collaborate to redefine the future of healthcare through AI, gene therapy, and venture-backed innovation RIYADH, Saudi Arabia, April 20, 2025 (GLOBE NEWSWIRE) -- MESH [...]

GenF20 Plus Under Review: Why Choose GenF20 Plus Over The Other Popular HGH Releaser Supplement?

20/04/2025 - 13:25

GenF20 Plus® is an all-natural supplement that is clinically-proven to reverse the signs of aging by boosting your Human Growth Hormone (HGH) levels. Limassol, Cyprus, April 20, 2025 (GLOBE NEWSWIRE) -- GenF20 Plus is [...]

Bioma Review 2025: Weight Loss Probiotic or Just Another Scam? - Ingredients & Side Effects Revealed !! By Bioma

20/04/2025 - 13:28

Birštonas Lithuania, April 20, 2025 (GLOBE NEWSWIRE) -- Are you looking for a reliable solution to improve your gut health and overall well-being? Bioma Probiotic could be the answer you've been searching for. This [...]

PhenQ Reviews - Best OTC Ozempic Alternative for Natural Weight Loss

20/04/2025 - 13:54

Albany, New York, April 20, 2025 (GLOBE NEWSWIRE) -- The Rise of Weight Management Challenges in the Modern World Across the globe, millions of people are grappling with weight loss more than ever, often feeling [...]

Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2025

19/04/2025 - 22:00

Company announcement – No. 9 / 2025 Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2025 Copenhagen, Denmark, April 19, 2025 – Zealand [...]

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

19/04/2025 - 22:05

Company announcement – No. 10 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, April [...]

Best CBD Gummies for Anxiety, Pain and Sleep By CBDCare 2025 Read What Makes Better From Blissful Wellness, Greenbow, Trifola Farms, Prima Ease CBD Gummies

19/04/2025 - 16:22

Clinically-Inspired CBDCare One Of the Best CBD Gummies 2025 Which Helps in Anxiety, Pain And Sleep Hamilton Township, NJ, April 19, 2025 (GLOBE NEWSWIRE) -- With high potential of therapeutic benefits, CBDCare is the [...]

VigRX Plus Reviews Uncovered: Shocking 2025 Report Reveals the Truth

19/04/2025 - 11:23

Shocking 2025 VigRX Plus review reveals real results, user stories, and expert insights. Find out if VigRX truly works before trying it. Read this now! Limassol, Cyprus, April 19, 2025 (GLOBE NEWSWIRE) -- Male [...]

Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025

18/04/2025 - 22:30

PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial results on Monday, May [...]

23andMe Provides Update Regarding Court-Supervised Sale Process

18/04/2025 - 22:30

SAN FRANCISCO, April 18, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today provided additional information on the [...]

Safety Shot, Inc. Postpones Record Date for Spin-Off and Distribution of Shares Common Stock of Caring Brands, Inc. - Updated

18/04/2025 - 22:40

JUPITER, FL, April 18, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company” or “Safety Shot”), today announced that the record date for the spin-off and distribution of shares of common stock, par [...]

Hapbee Applies for Management Cease Trade Order

18/04/2025 - 22:45

VANCOUVER, British Columbia, April 18, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB ) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company, announces that it [...]

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

18/04/2025 - 23:30

SAN CARLOS, Calif., April 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel [...]

Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details

18/04/2025 - 20:09

BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will [...]

IBA – ACQUISITION D’ACTIONS PROPRES

18/04/2025 - 20:10

Publication immédiate – 18 avril 2025 Louvain-la-Neuve, Belgique, 18 avril 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam [...]

IBA – ACQUISITION OF OWN SHARES

18/04/2025 - 20:10

Immediate Release – April 18 th , 2025 Louvain-la-Neuve, Belgium, April 18 th , 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion [...]

Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application

18/04/2025 - 21:00

TARRYTOWN, N.Y., April 18, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding [...]

Communiqué de presse : Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée

18/04/2025 - 17:15

Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée Aux États-Unis, le Dupixent est indiqué à plus de 300 000 [...]